Publication | Open Access
Attenuated FOLFIRINOX in the salvage treatment of gemcitabine‐refractory advanced pancreatic cancer: a phase II study
28
Citations
22
References
2018
Year
Attenuated FOLFIRINOX may be promising as a second-line therapy for gemcitabine-refractory pancreatic cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1